Quantcast

Latest Torcetrapib Stories

2006-03-13 12:06:29

NEW YORK (Reuters) - Pfizer Inc. on Monday said its Lipitor cholesterol medicine improved kidney function in patients with heart disease in a large clinical study. The drugmaker also said improvement in kidney function was significantly greater among patients taking the 80 milligram highest dose of Lipitor, the world's top-selling prescription drug. The data from the 8,000-patient study was presented at the American College of Cardiology annual scientific meeting in Atlanta.

2006-01-19 15:18:33

NEW YORK (Reuters Health) - Treatment with Lipitor (atorvastatin), one of the popular cholesterol-lowering "statin" drugs, can help the heart pump better in patients with heart failure, according to a new report. By contrast, findings from a much smaller study showed that aside from lowering cholesterol levels, Lipitor did not benefit patients with heart failure. Both reports are published in the Journal of the American College of Cardiology. "Although the reasons for these...

2006-01-19 15:15:00

NEW YORK -- Treatment with Lipitor (atorvastatin), one of the popular cholesterol-lowering "statin" drugs, can help the heart pump better in patients with heart failure, according to a new report. By contrast, findings from a much smaller study showed that aside from lowering cholesterol levels, Lipitor did not benefit patients with heart failure. Both reports are published in the Journal of the American College of Cardiology. "Although the reasons for these discrepant findings are not known,...

2005-11-15 16:19:55

BOSTON (Reuters) - Pfizer Inc. said on Tuesday its experimental cholesterol drug torcetrapib, combined with its multibillion-dollar cholesterol drug Lipitor, significantly increased levels of "good" cholesterol while significantly lowering "bad" cholesterol. The world's biggest drug company said promising results of two mid-stage, or Phase II, studies presented at the annual meeting of the American Heart Association in Dallas determined the company to continue into the final stage of...

2005-11-15 11:23:02

BOSTON (Reuters) - Pfizer Inc. said on Tuesday its experimental cholesterol drug torcetrapib, combined with its multibillion-dollar selling cholesterol drug Lipitor, significantly increased levels of "good" cholesterol while significantly lowering "bad" cholesterol. The world's biggest drug company said results of two mid-stage, or Phase II, studies presented at the annual meeting of the American Heart Association in Dallas were promising enough that the company will continue into...

2005-09-27 09:02:11

CHICAGO (Reuters) - Pfizer Inc. said on Tuesday U.S. regulators have approved its blockbuster cholesterol drug Lipitor to reduce the risk of stroke and heart attack in diabetic patients. Pfizer said the approval is for patients with type 2, or adult onset, diabetes who have no signs of heart disease but with other risk factors for the condition. Pfizer said Lipitor also received approval to reduce the risk of stroke in people without evidence of heart disease but with multiple risk...

2004-12-01 00:00:07

Dec. 1--It's common knowledge that high cholesterol increases the risks of heart attack. But having too little of a certain type of cholesterol can be hazardous as well, and currently there isn't much doctors can do, except urge their patients to lose weight and exercise. On Tuesday, Pfizer Inc., the world's largest drugmaker, outlined its plans to change that by combining its best-selling Lipitor cholesterol-lowering drug with another drug that boosts the "good" type of...

2004-11-30 15:00:10

GROTON, Conn., Nov. 30 /PRNewswire-FirstCall/ -- Pfizer Inc said today it is on track to achieve its goal of submitting 20 New Drug Application (NDA) filings in the five-year period ending in 2006, reflecting the industry's premier research and development pipeline. In a presentation to financial analysts at the company's largest research and development site, Pfizer said it will have completed 12 of these 20 regulatory filings by the end of 2004. Pfizer also announced that its drug...


Word of the Day
humgruffin
  • A terrible or repulsive person.
Regarding the etymology of 'humgruffin,' the OED says (rather unhelpfully) that it's a 'made-up word.' We might guess that 'hum' comes from 'humbug' or possibly 'hum' meaning 'a disagreeable smell,' while 'gruffin' could be a combination of 'gruff' and 'griffin.'